Success of AI-driven healthcare depends on robust IP strategies

Artificial Intelligence in healthcare is undoubtedly having a moment. It is already transforming fields such as medical imaging where AI revolutionises image analysis, expanding its reach and improving overall quality. With the UK Government planning an AI revolution, healthcare AI start-ups stand to benefit, but only if they place Intellectual Property (IP) at the centre of their business strategy.

Earlier this year, prime minister Theresa May called for health charities, the NHS and the AI community to work together by pooling data. “The development of smart technologies to analyse great quantities of data quickly and with a higher degree of accuracy than is possible by human beings opens up a whole new field of medical research and gives us a new weapon in our armoury in the fight against disease”, she said during her speech.

Narrow AI, the only type of AI humans have mastered so far, identifies patterns and correlations from data that would take a human years to achieve. It amounts to testing an algorithm using large quantities of data and using the results to improve the algorithm, which leads to highly accurate results over time. Therefore, the success of Theresa May’s AI revolution depends on the providers of AI-driven healthcare products having large-scale access to patient data.

Continue reading this article on Digital Health Age to find out how startups in this field can protect their innovations.